Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib.
暂无分享,去创建一个
C. Unger | M. Radtke | E. Brendel | D. Voliotis | K. Mross | S. Steinbild | O. Christensen | D. Gmehling | F. Baas
暂无分享,去创建一个
C. Unger | M. Radtke | E. Brendel | D. Voliotis | K. Mross | S. Steinbild | O. Christensen | D. Gmehling | F. Baas